Galmed Pharmaceuticals forms partnership with OnKai
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
Pheezee is designed to assess musculoskeletal and neuromuscular health.
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
UAB Medexy's first order under the Distribution Agreement is for over 5000 units of SHIR and RELIEF&GO products
The partnership will capitalize on the combined capabilities of the two organizations
Subscribe To Our Newsletter & Stay Updated